{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:53:27Z","timestamp":1772751207076,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,10,16]],"date-time":"2007-10-16T00:00:00Z","timestamp":1192492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10620-007-9919-9","type":"journal-article","created":{"date-parts":[[2007,10,15]],"date-time":"2007-10-15T18:33:52Z","timestamp":1192473232000},"page":"830-835","source":"Crossref","is-referenced-by-count":161,"title":["Terlipressin and Albumin in Patients with Cirrhosis and Type I Hepatorenal Syndrome"],"prefix":"10.1007","volume":"53","author":[{"given":"Sergio","family":"Neri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Pulvirenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Malaguarnera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Cosimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Bertino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Ignaccolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasiano","family":"Siringo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Castellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,16]]},"reference":[{"key":"9919_CR1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo V, Gin\u00e8s P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scholmerich J (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23:164\u2013176","journal-title":"Hepatology"},{"issue":"3","key":"9919_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2036.2004.02113.x","volume":"20","author":"P Angeli","year":"2004","unstructured":"Angeli P (2004) Prognosis of hepatorenal syndrome\u2014has it changed with current practice? Aliment Pharmacol Ther 20(3):44\u201346","journal-title":"Aliment Pharmacol Ther"},{"key":"9919_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.coph.2003.10.007","volume":"4","author":"K Barada","year":"2004","unstructured":"Barada K (2004) Hepatorenal syndrome: pathogenesis and novel pharmacological targets. Curr Opin Pharmacol 4:189\u2013197","journal-title":"Curr Opin Pharmacol"},{"key":"9919_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biocel.2004.06.007","volume":"37","author":"M Guevara","year":"2005","unstructured":"Guevara M, Rod\u00e9s J (2005) Hepatorenal syndrome. Int J Biochem Cell Biol 37:22\u201326","journal-title":"Int J Biochem Cell Biol"},{"key":"9919_CR5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hep.20313","volume":"40","author":"P Gin\u00e8s","year":"2004","unstructured":"Gin\u00e8s P, Guevara N, Perez-Villa F (2004) Management of hepatorenal syndrome: another piece of the puzzle. Hepatology 40:16\u201318","journal-title":"Hepatology"},{"key":"9919_CR6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1572-0241.2005.40952.x","volume":"100","author":"A Gardenas","year":"2005","unstructured":"Gardenas A (2005) Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol 100:460\u2013467","journal-title":"Am J Gastroenterol"},{"key":"9919_CR7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P Gines","year":"2003","unstructured":"Gines P, Guevara M, Arroyo V, Rodes J (2003) Hepatorenal syndrome. Lancet 362:1819\u20131827","journal-title":"Lancet"},{"key":"9919_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1440-1746.2004.03226.x","volume":"19","author":"G Therapondos","year":"2004","unstructured":"Therapondos G, Stanley AJ, Hayes PC (2004) Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study. J Gastroenterol Hepatol 19:73\u201377","journal-title":"J Gastroenterol Hepatol"},{"key":"9919_CR9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/jhep.2003.50108","volume":"37","author":"C Antoniades","year":"2003","unstructured":"Antoniades C, Auzinger G (2003) Terlipressin and albumin for the hepatorenal syndrome. Hepatology 37:946","journal-title":"Hepatology"},{"key":"9919_CR10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","volume":"17","author":"I Colle","year":"2002","unstructured":"Colle I, Durand F, Pessione F, Rassiat E, Bernuau J, Barriere E, Lebrec D, Valla DC, Moreau R (2002) Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with terlipressin: a retrospective analysis. J Gastroenterol Hepatol 17:882\u2013888","journal-title":"J Gastroenterol Hepatol"},{"key":"9919_CR11","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, Guevara M, Bataller R, Jimenez W, Arroyo W, Rodes J (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36:941\u2013948","journal-title":"Hepatology"},{"key":"9919_CR12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","volume":"18","author":"P Solanki","year":"2003","unstructured":"Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK (2003) Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 18:152\u2013156","journal-title":"J Gastroenterol Hepatol"},{"key":"9919_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","volume":"33","author":"J Uriz","year":"2000","unstructured":"Uriz J, Gines P, Cardenas A, Sort P, Jimenez W, Salmeron JM, Bataller R, Mas A, Navasa M, Arroyo V, Rodes J (2000) Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 33:43\u201348","journal-title":"J Hepatol"},{"key":"9919_CR14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","volume":"362","author":"C Duvoux","year":"2002","unstructured":"Duvoux C, Zanditenas D, Hezode C, Chauvat A, Monin JL,Roudot-Thoraval F, Mallat A, Dhumeaux D (2002) Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 362:374\u2013380","journal-title":"Hepatology"},{"key":"9919_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.50.1.90","volume":"50","author":"R Moreau","year":"2002","unstructured":"Moreau R, Assellah T, Condat B, de Kerguenec C, Pessione F, Bernard B, Poynard T, Binn M, Grange JD, Valla D, Lebrec D (2002) Comparison of the effects of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomized pilot study. Gut 50:90\u201394","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-007-9919-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-007-9919-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-007-9919-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:43:46Z","timestamp":1559245426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-007-9919-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,16]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9919"],"URL":"https:\/\/doi.org\/10.1007\/s10620-007-9919-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,16]]}}}